Levin Capital Strategies LP Lowered Medtronic Plc (MDT) Stake; Advanced Semiconductor Engnrng (ADR) (ASX) Had 2 Bulls

June 20, 2017 - By Winifred Garcia

Among 3 analysts covering Advanced Semiconductor Engineering (NYSE:ASX), 2 have Buy rating, 0 Sell and 1 Hold. Therefore 67% are positive. Advanced Semiconductor Engineering had 3 analyst reports since May 31, 2016 according to SRatingsIntel. The rating was upgraded by UBS on Tuesday, May 31 to “Buy”. The rating was upgraded by Nomura to “Buy” on Thursday, May 26. The firm earned “Neutral” rating on Friday, November 25 by Goldman Sachs. See Advanced Semiconductor Engnrng Inc (ADR) (NYSE:ASX) latest ratings:

Levin Capital Strategies Lp decreased Medtronic Plc (MDT) stake by 61.69% reported in 2016Q4 SEC filing. Levin Capital Strategies Lp sold 41,380 shares as Medtronic Plc (MDT)’s stock rose 5.51%. The Levin Capital Strategies Lp holds 25,700 shares with $1.83M value, down from 67,080 last quarter. Medtronic Plc now has $121.82 billion valuation. The stock rose 0.11% or $0.1 reaching $89.09. About 1.82M shares traded. Medtronic plc. Ordinary Shares (NYSE:MDT) has risen 4.04% since June 20, 2016 and is uptrending. It has underperformed by 12.66% the S&P500.

Advanced Semiconductor Engineering, Inc. is a well-known provider of semiconductor packaging and testing services. The company has market cap of $10.20 billion. The Firm offers a range of semiconductors packaging, testing and electronic manufacturing services . It has a 16.23 P/E ratio. The Company’s divisions include Packaging, Testing, EMS and Others.

About 243,517 shares traded. Advanced Semiconductor Engnrng Inc (ADR) (NYSE:ASX) has risen 38.27% since June 20, 2016 and is uptrending. It has outperformed by 21.57% the S&P500.

Levin Capital Strategies Lp increased Stericycle Inc (NASDAQ:SRCL) stake by 48,921 shares to 172,968 valued at $13.33M in 2016Q4. It also upped Nxp Semiconductors N V (NASDAQ:NXPI) stake by 127,897 shares and now owns 242,158 shares. Occidental Pete Corp Del (NYSE:OXY) was raised too.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: